Skip to content

Membrane Stripping for Cervical Ripening

Evaluation of Stripping for Cervical Ripening - A Randomized Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06591247
Acronym
Stripping
Enrollment
400
Registered
2024-09-19
Start date
2024-08-07
Completion date
2027-12-31
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balloon Induction, Cervical Ripening, Induction of Birth, Labor, Induced, Membrane Stripping, Pregnancy Related

Brief summary

The goal of this interventional study is to evaluate the effectiveness of membrane stripping in cervical ripening compared to double balloon catheter induction. The study population consists of women undergoing labor induction. The main questions it aims to answer are: 1. Is membrane stripping as effective as double balloon catheter induction in cervical ripening? 2. What is the influence of membrane stripping on the time required for cervical ripening, delivery duration, and maternal and fetal outcomes compared to balloon induction.

Interventions

DEVICEDouble Baloon Catheter

A double Baloon Catheter will be inserted for 12 hours to one of the arms of the study

Stripping will be considered as 3-5 rotations of separating the amniotic sac from the cervix and will be perfomed twice (every 4-6 hours)

DRUGPGE2

A PGE2 vaginal pessary (Cervidil) will be inserted for 12-24 hours

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18 and above * Patients with a cervical dilation of at least 1 cm * Full-term pregnancy * Cephalic presentation * No contraindication to vaginal delivery

Exclusion criteria

* Patients with rupture of membranes * Patients who do not require cervical ripening and proceed directly to the delivery room for induction with oxytocin * Patients for whom the use of a double-balloon catheter/PGE2 is contraindicated * Twin pregnancies * Pregnancies with macrosomic fetuses where vaginal delivery is contraindicated * Patients with maternal or fetal pathologies that do not allow for vaginal delivery due to concerns about fetal or maternal distress

Design outcomes

Primary

MeasureTime frameDescription
Rates of successful cervical ripening at the end of 12 hours, duration of cervical ripeningfrom 12 hours after intervention until patient&s discharge or 150 hours, whichever came first, assessed up to 100 monthsWhat percentage of the women in this arm had a successful cervical ripening after 12 hours

Secondary

MeasureTime frameDescription
Rates of vaginal delivery within 24 hoursfrom 12 hours after intervention until patients discharge or 150 hours, whichever came first, assessed up to 100 monthsWhat percentage of the women in this arm delivered within 24 hours

Countries

Israel

Contacts

CONTACTGal Cohen, MD
galcwork@gmail.com+972545915788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026